top of page

10 Things To Know About the Proposed Federal PBM Transparency Rule (2026-01907)

  • Feb 9
  • 2 min read

At KneeTie Go Run Go, we closely monitor regulatory developments that influence healthcare affordability, employer-sponsored health plan sustainability, and patient access to medications. A newly proposed federal rule seeks to significantly increase transparency and accountability among Pharmacy Benefit Managers (PBMs). Below are key insights healthcare leaders, employers, and policy stakeholders should understand


1️⃣ PBMs Must Disclose How They Get Paid: PBMs would be required to fully disclose all direct and indirect compensation received from drug manufacturers, pharmacies, brokers, and third parties.👉 Enables employers to assess fee reasonableness and identify potential conflicts of interest.


2️⃣ Disclosures Must Be Provided BEFORE Contracts Are Signed: PBMs must provide compensation transparency before entering or renewing employer health plan agreements.👉 Allows employers to compare vendors and negotiate stronger, data-driven contracts.


3️⃣ Applies Primarily to Self-Insured Employer Health Plans: The rule focuses on ERISA-covered self-insured employer plans covering more than 100 million Americans.👉 Reinforces fiduciary responsibility to control healthcare spending responsibly.


4️⃣ Brokers and Consultants Must Also Disclose Payments: Disclosure includes referral fees, commissions, shared rebates, and per-prescription payments.👉 Helps eliminate hidden financial steering incentives.


5️⃣ Future Compensation Must Be Disclosed: PBMs must report reasonably expected future compensation, not just historical payments.👉 Prevents undisclosed revenue streams from emerging after contracts are finalized.


6️⃣ Employers Gain Expanded Audit Rights: The rule proposes mechanisms allowing fiduciaries to verify disclosures, audit payment accuracy, and monitor compliance.👉 Strengthens employer oversight and transparency enforcement.


7️⃣ Enhanced Spread Pricing Transparency PBMs frequently generate revenue through spread pricing — charging employers more than pharmacies are reimbursed.👉 The rule aims to expose these pricing differentials and clarify drug cost drivers.


8️⃣ Manufacturer Rebates and Incentives Must Be Disclosed Includes rebates, administrative fees, price-protection payments, and other manufacturer incentives.👉 Addresses concerns that rebates may influence drug selection and pricing strategies.


9️⃣ Addresses Conflicts in Formulary DesignPBMs influence drug coverage decisions, step therapy protocols, prior authorization requirements, and substitution strategies.👉 Employers gain visibility into whether clinical decisions may be financially influenced.


🔟 Part of Broader Federal Drug Pricing Reform EffortsThis proposal aligns with national initiatives focused on lowering prescription drug costs, improving competition, and increasing healthcare transparency.

Healthcare transparency is foundational to improving affordability, strengthening employer-sponsored coverage, and ensuring patient-centered care delivery. KneeTie Go Run Go remains committed to supporting policy awareness, innovation, and solutions that enhance healthcare system accountability.


The domain www.dubaitelemedicine.com is for sale. Please contact us at www.kneetie.com#KneeTie #Stroke #youtube/kneetiegorungo #DubaiTelemedicine


#PBM#PBMTransparency#DrugPricing#DrugCostReform#PharmacyBenefits#HealthcareTransparency#HealthcarePolicy#EmployerHealthcare#ValueBasedCare#HealthcareLeadership

 
 
 

Comments

About Dr. Viveck Baluja and KneeTie Vascular Neurology

Dr. Viveck Baluja, MD, is a board-certified vascular neurologist (American Board of Psychiatry and Neurology — Vascular Neurology) practicing telemedicine across California, Michigan, and Colorado, with additional consultation services available to international families, particularly in India.

KneeTie offers three focused services: emergency stroke second opinions delivered within 24 hours, traumatic brain injury (TBI) consultations for survivors and caregivers, and same-day adult ADHD evaluations for residents of CA, MI, and CO.

Stroke Second Opinion

After a stroke, families often have minutes to make decisions. Dr. Baluja provides a second set of expert eyes from a board-certified vascular neurologist — reviewing imaging, hospital records, and current treatment — typically within 24 hours of request. Common questions include: Was tPA appropriate? Should we pursue thrombectomy? What is the recovery outlook? What rehabilitation makes sense?

TBI Consultation

Traumatic brain injury recovery is rarely linear. Dr. Baluja helps patients and families understand recovery timelines, treatment options, post-concussion syndrome, and red flags that warrant emergency evaluation. Consultations typically last 50 minutes and are scheduled within the same week.

Same-Day Adult ADHD Evaluation

A real evaluation by a board-certified neurologist — not a 7-minute screening. Dr. Baluja's ADHD evaluations include comprehensive history, sleep and lifestyle assessment, and behavioral strategy alongside any medication discussion. Available same-day for residents of California, Michigan, and Colorado.

Why a Vascular Neurologist?

Vascular neurology is a subspecialty focused on stroke, cerebrovascular disease, and brain blood flow — among the rarest neurology subspecialties in the U.S. Most online telehealth services use general practitioners or nurse practitioners. KneeTie is led by a board-certified vascular neurologist with full state licensure and HIPAA-compliant telehealth infrastructure.

Schedule a consultation: Use the booking calendar above to choose a service and reserve a time. For active stroke or post-tPA emergencies, email gorungo@kneetie.com directly with "URGENT" in the subject line.

© 2020 KneeTie, Jagannatha Health LLC 

bottom of page